CIK 0001817713
- Large accelerated filer
Janux Therapeutics, Inc.
Sign in to watch- Ticker
- JANX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822289112
- Phone
- +1 858-751-4493
- Business address
- 10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 8-K Event Results of operations
- 8-K Event Other events
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Executive or director change
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Bylaws or fiscal year change · Other events
Page 3 of 3 · 60 filings